US approves Alzheimer's drug that modestly slows disease

Singapore News News

US approves Alzheimer's drug that modestly slows disease
Singapore Latest News,Singapore Headlines
  • 📰 AP
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

U.S. health officials have approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.

also from Biogen and Eisai — was “rife with irregularities,” including a number of meetings with drug company staffers that went undocumented.

The drug will cost about $26,500 for a typical year’s worth of treatment. Eisai said the price reflects the drug’s benefit in terms of improved quality of life, reduced burdens for caregivers and other factors. The company pegged its value at over $37,000 per year, but said it priced it lower to reduce costs for patients and insurers. An independent group that assesses drug value recently said the drug would have to be priced below $20,600 per year to be cost-effective.

There is little consensus on whether that difference translates into real benefits for patients, such as greater independence.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AP /  🏆 728. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer’s drug that slows cognitive decline gets FDA approvalAlzheimer’s drug that slows cognitive decline gets FDA approvalThe drug, lecanemab, removes a sticky protein from the brain called amyloid beta, which is thought to play a key role in the memory-robbing illness.
Read more »

FDA Approves Alzheimer's Drug That Modestly Slows DiseaseFDA Approves Alzheimer's Drug That Modestly Slows DiseaseThe drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s.
Read more »

FDA approves Leqembi, Alzheimer's drug that modestly slows diseaseFDA approves Leqembi, Alzheimer's drug that modestly slows diseaseALZHEIMER'S DRUG: The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s by targeting the disease's underlying biology. MORE:
Read more »

The Toll That Alzheimer's Takes On The Mother/Daughter Relationship - The Diary of An Alzheimer's CaregiverThe Toll That Alzheimer's Takes On The Mother/Daughter Relationship - The Diary of An Alzheimer's CaregiverOne of the first things to go out the window when you’re life has been taken over by Alzheimer’s disease is the mother/daughter relationship. It’s stretched, pulled, and kneaded until it resembles something well… unrecognizable. Your mother has known you as long as you’ve known you. The first arms that cuddled you when you cried, […]
Read more »

Report shares new details about death possibly linked to experimental Alzheimer's drug | CNNReport shares new details about death possibly linked to experimental Alzheimer's drug | CNNThe death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug, a new report shows.
Read more »

Scientists Discover That Hibiscus Tea Could Defeat Alzheimer’s DiseaseScientists Discover That Hibiscus Tea Could Defeat Alzheimer’s DiseaseThere are many reasons to enjoy a cup of ruby red hibiscus tea, including its ability to warm the body in the winter, boost the immune system, regulate blood pressure, and aid in weight loss. Now, research has found that it could defeat Alzheimer's disease. Professor Kyong-Tai Kim and Ph.D. candi
Read more »



Render Time: 2025-04-01 18:39:34